65172 Federal Register / Vol. 83, No. 243 / Wednesday, December 19, 2018 / Notices 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990–New–30D and project title for 

reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Cohort 3 Teen 

Pregnancy Prevention Performance 

Measure Data. 

Type of Collection: New, 0990– 

NEW—Office of Adolescent Health. 

Abstract: The Office of Adolescent 

Health Requests a new clearance for the 

collection of performance measures 

from the cohort 3 Teen Pregnancy 

Prevention (TPP) grant recipients, 

awarded in Fall 2018. Phase 1 cohort 3 

TPP grants shall be issued in for an 

anticipated 2 year period of 

performance. A subset of successful 

Phase 1 grantees will be selected for 

Phase 2 grants. A 3 year clearance is 

requested. FY2018 TPP phase 1 grant 

recipients will be expected to report 

data twice each year. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

TPP Grantee (Grantee Form) .......................................................................... 19 2 7 266 

TPP Grantee (Participant Form) ...................................................................... 19 2 8 304 

TPP Program Participant ................................................................................. 14,250 2 10/60 4,750 

Total .......................................................................................................... 14,269 2 15 5,320 

Terry Clark, 

Office of the Secretary, Asst Paperwork 

Reduction Act Reports Clearance Officer. 

[FR Doc. 2018–27470 Filed 12–18–18; 8:45 am] 

BILLING CODE 4168–11–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; Minority Health and 

Health Disparities Research Training 

Program. 

Date: February 7–8, 2019. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Richard C. Palmer, DRPH, 

Health Scientist Administrator, National 

Institute on Minority Health and Health 

Disparities, National Institutes of Health, 

6707 Democracy Blvd., Suite 800, Bethesda, 

MD 20906, (301) 451–2432, richard.palmer@

nih.gov. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; NIMHD Mentored 

Career Development Awards (Ks). 

Date: March 4, 2019. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Gateway Building, 533K, 7201 Wisconsin 

Avenue, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Xinli Nan, M.D., Ph.D., 

Scientific Review Officer, National Institute 

on Minority Health and Health Disparities, 

National Institutes of Health Scientific 

Review Branch, OERA, 6707 Democracy 

Blvd., Suite 800, Bethesda, MD 20892, (301) 

594–7784, Xinli.Nan@nih.gov. 

Any interest person may file written 

comments with the committee by 

forwarding the statement to the Contact 

Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Dated: December 13, 2018. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–27375 Filed 12–18–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Center for 

Translational ImmunoEngineering (2019/05). 

Date: March 6, 2019. 


amozie on DSK3GDR082PROD with NOTICES1